Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Facilities Profit When Tech Meets Trash
May 28, 2026 Blake Gordon

Facilities Profit When Tech Meets Trash

May 26, 2026 Stephen P. Ashkin

Businesses Score With Sustainability Reporting

May 22, 2026 Jeff Cross

Stop the Information Dump: Why Clearer Proposals Win More Cleaning Contracts

Sponsored Articles

Novonesis
May 18, 2026 Sponsored by Novonesis

From the Lab to the Reprocessing Floor: How Enzymatic Detergents Get Tested, Chosen, and Trusted

May 18, 2026 Sponsored by Novonesis

Where Cleaning Contracts Are Really Won or Lost

May 15, 2026

100 Years of Battery Power Innovation

Recent News

crowd networking

Most Americans Concerned About Infectious Disease Risk in Public Settings

Tick Bites Sending Many to ER

NOAA Predicts Below-Normal 2026 Atlantic Hurricane Season